Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AdaptHealth Corp. Director's Dealing 2021

Feb 4, 2021

32107_dirs_2021-02-04_f1c62c68-3211-4a86-86f8-bfcd7852a4aa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AdaptHealth Corp. (AHCO)
CIK: 0001725255
Period of Report: 2021-02-02

Reporting Person: Peloton Equity AeroCare SPV I, L.P. (Director)
Reporting Person: Peloton Equity AeroCare SPV II, L.P. (Director)
Reporting Person: Peloton Equity I, L.P. (Director)
Reporting Person: Peloton Equity GP, LLC (Director)
Reporting Person: FERRER CARLOS A (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Class A Common Stock 3466826 Direct
Class A Common Stock 328260 Indirect
Class A Common Stock 1108519 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series C Preferred Stock $ Class A Common Stock (3214007) Direct
Series C Preferred Stock $ Class A Common Stock (306087) Indirect
Series C Preferred Stock $ Class A Common Stock (1033644) Indirect

Footnotes

F1: On December 1, 2020, the Issuer entered into Agreement and Plan of Merger (the "Merger Agreement") with AH Apollo Merger Sub Inc. ("Merger Sub I"), AH Apollo Merger Sub II Inc. ("Merger Sub II"), Peloton Equity, LLC (the "Stockholder Representative") and AeroCare Holdings, Inc. ("AeroCare"). The effective time of the merger occurred on February 1, 2021, at which time the outstanding shares of the Common Stock and Series C Preferred Stock of AeroCare were converted into the right to receive, among other things, shares of the Issuer's Class A Common Stock and Series C Preferred Stock, respectively, pursuant to the Merger Agreement.

F2: Shares held by Peloton Equity AeroCare SPV I, L.P. ("Peloton AeroCare I"). Peloton Equity GP, LLC ("Peloton Equity GP") is the general partner of Peloton AeroCare I. Carlos Ferrer and Theodore B. Lundberg are the managing members of Peloton Equity GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

F3: Shares held by Peloton Equity AeroCare SPV II, L.P. ("Peloton AeroCare II"). Peloton Equity GP is the general partner of Peloton AeroCare II. Carlos Ferrer and Theodore B. Lundberg are the managing members of Peloton Equity GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

F4: Shares held by Peloton Equity I, L.P. ("Peloton Equity I"). Peloton Equity GP is the general partner of Peloton Equity I. Carlos Ferrer and Theodore B. Lundberg are the managing members of Peloton Equity GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

F5: Upon approval by the stockholders of the Issuer pursuant to the terms of the Merger Agreement, each share of Series C Preferred Stock will be convertible on a 100-for-one basis into the number of shares of the Issuer's Class A Common Stock shown in Column 3, subject to adjustments as set forth in the Certificate of Designation, Preferences and Rights of Series C Convertible Preferred Stock, Par Value $0.0001, of AdaptHealth Corp. dated as of January 29, 2021. The Series C Preferred Stock has no expiration date.